[1]
D. Djukić-Ćosić, “Toxicological aspect of immunomodulators: friend or foe in increasing the effectiveness of cancer immunotherapy”, arhfarm, vol. 72, no. Suppl. 4, pp. S167-S168, Oct. 2022, Accessed: Nov. 19, 2026. Available: https://test.aseestant.ceon.rs/index.php/arhfarm/article/view/38633